Citi raises Marex Group stock target to $45, maintains Buy rating

Published 07/03/2025, 11:50
Citi raises Marex Group stock target to $45, maintains Buy rating

On Friday, Citi analyst Chris Allen increased the price target for Marex Group PLC (NASDAQ: MRX) shares to $45.00, up from the previous $39.00, while reiterating a Buy rating on the stock. Currently trading at $36.27, the stock sits between its 52-week range of $18.13 to $40.05. According to InvestingPro analysis, Marex appears slightly overvalued at current levels. The adjustment follows Marex Group’s continued strong performance in the fourth quarter, which saw the company gaining market share and experiencing robust growth in client balances.

Marex Group’s recent success has been attributed to sustained momentum across its various business segments, reflected in its impressive 93% return over the past year and 25.2% revenue growth. The company has also benefited from heightened volatility and activity in the commodities markets at the beginning of the year, which is expected to provide near-term positive effects.

Looking into the future, Marex Group is poised for further growth through both product and geographical expansion. Notably, the impending acquisitions of Aarna Capital and Hamilton Court are anticipated to be finalized in the upcoming months, and these are seen as significant steps in the company’s growth strategy.

Citi’s analyst underscored the firm’s favorable outlook for Marex Group, highlighting its specialized market position and potential for market share increases. Marex Group’s leverage to the energy and commodities sectors, coupled with its regional expansion plans and focus on commercial clients, were also cited as reasons for the positive assessment.

In summary, Citi maintains a confident stance on Marex Group’s prospects, emphasizing the company’s unique positioning and the opportunities ahead that are likely to drive continued success and growth in its operations. With a market cap of $2.64 billion and an overall "GREAT" financial health score from InvestingPro, which offers comprehensive analysis and additional ProTips in its detailed research report, Marex Group demonstrates strong fundamentals for potential investors.

In other recent news, Citi analyst Chris Allen has raised the price target for Marex Group PLC shares to $39.00 from $36.00, maintaining a Buy rating on the stock. This adjustment reflects revised estimates based on the current market environment, with strong industry volumes reported in the fourth quarter of 2024. Citi projects that Marex Group could exceed its adjusted operating profit guidance for the fiscal year 2024, initially set at $300-305 million, with an updated forecast of $310 million. The analyst remains optimistic about the company’s volume outlook and potential revenue growth, partly due to market volatility.

Additionally, Citi highlights Marex Group’s strong niche positioning and leverage in the energy and commodities sectors as factors for potential market share gains. The company’s regional expansion and focus on commercial clients are also viewed favorably. Marex Group’s recent acquisitions of Aarna and Hamilton Court, expected to close in the first quarter of 2025, are anticipated to contribute approximately 10% to the total profit thereafter. The continued endorsement from Citi is supported by these strategic moves and market conditions, with a reiterated Buy/High Risk rating for Marex Group PLC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.